Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy: a Randomized, Non-inferiority Trial

NCT05341817 is registered in ClinicalTrials.gov with KK Women's and Children's Hospital as lead sponsor.

NCT NCT05341817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05341817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy: a Randomized, Non-inferiority Trial
Lead sponsor
KK Women's and Children's Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
November 22, 2022
Completion date
November 30, 2025
Enrollment
144 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abortion in first trimester